INTRODUCTION
Tubulin Polymerization Promoting Protein (TPPP/p25) is a 25 kDa disordered microtubule-associated protein that was first identified in the brain [1] where it plays a crucial role in the differentiation of oligodendrocytes [2] and is involved in the development, maintenance and stability of oligodendrocyte projections due to the modulation of the dynamics and stability of microtubule network [3] [4] [5] . Oligodendrocytes are the major constituents of the myelin sheath. TPPP/p25 directly interacts with histone deacetylase 6, inhibits its activity, and therefore regulates acetylation of tubulin [5] and influence differentiation, cellular polarization and migration [6] [7] [8] [9] .
While the normal function of TPPP/p25 is to modulate and stabilize the microtubule network [3] [4] [5] by it bundling and acetylation enhancing activity due to its interaction with tubulin deacetylases (histone deacetylase 6, sirtuin 2), it can also directly interact with α-synuclein [10] , hallmark protein of synucleinopathies, and play a role in its pathological oligomerisation/aggregation. TPPP/p25 is implicated in the development of synucleinopathies such as Parkinson's disease and Multiple System Atrophy, when α-synuclein and TPPP/p25 are co-localized and co-enriched in the inclusions [11] [12] [13] [14] .
TPPP/p25 has a zinc binding motif [15, 16] , the specific binding of the bivalent zinc cation to TPPP/p25 induces structural changes/dimerization coupled with stabilization that counteracts its proteolytic degradation [17] . Thus, zinc may control the intracellular level of TPPP/p25, playing role in its physiological as well as its pathological functions [17] . Zinc levels can be altered in different diseases of the eye [18] and a recent study showed that optic nerve (ON) injuries can elevate zinc levels not only in the ON but also in the retina [19] . In this paper, we set out to investigate whether the intracellular TPPP/p25 level could be affected by the zinc level.
MATERIALS AND METHODS
Antibodies -The list of antibodies used for the experiments can be found in Supplementary Table 1 . Mouse eyes -Eyes from 6 months old female mice were used in this study from a previous experiment in which zinc supplementation had a significant behavioural effect [20] . The eyes were dissected from double transgenic mice overexpressing human APP and ApoE4 as well as wild type litter mates [20] . Four wild type and 4 transgenic animals were given drinking water without zinc supplementation to establish baseline.
In addition, 4 transgenic mice were given drinking water supplemented with 10 ppm (0.153 mM) zinc carbonate from the age of 2 months The zinc-enhanced water was prepared by dissolving 10,000 mg/L zinc in 5% HNO3 and adding Na2CO3 to buffer the solution to pH 7.0 [20] .
Preparation of human retina extract -Cell extracts were prepared from three unfixed human eyes that were flat mounted before peripheral and central retina tissues were excised. After excision, the tissues were homogenized in buffer A (10 mM tris(hydroxymethyl)aminomethane, 150 mM NaCl, 5 mM ethylenediaminetetraacetic acid pH 7.4 containing 1 μg/ml leupeptin, 1 μg/ml pepstatin, 10 μM 4-(2-aminoethyl) benzenesulfonyl fluoride hydrochloride, 1 mM benzamidine, 1% Triton X-100) at a 1:4 ratio of tissue and buffer by a Potter-homogenizer. The homogenates were centrifuged at 17000 g for 10 min at 4°C, and the supernatants were used for further experiments. Bovine brain extract was prepared similarly. The protein concentration of the retina/brain extract was determined by the Bradford method [21] using the Bio-Rad protein assay kit.
Purification of human wild type TPPP/p25 and bovine tubulin -Human recombinant full
length TPPP/p25 with a His-tag was expressed in E. coli BL21 (DE3) cells and isolated on HIS-Select™ Cartridge (Sigma-Aldrich) as described previously [11, 22] . Tubulin was prepared from bovine brain according to the method of Na and Timasheff [23] . TPPP/p25 concentration was determined from the absorbance at 280 nm using an extinction coefficient of 10095 M −1 *cm −1 .
Western blot -Retina samples were analysed by sodium dodecyl sulphate polyacrylamide gel electrophoresis, and were electrotransferred onto Immobilon-PSQ transfer membranes and labelled with antibodies: TPPP/p25 in a dilution of 1:5000 [11] or with tubulin (1:5000; Sigma T9026), acetylated tubulin (1:5000; Sigma T6793) or glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in mouse (1:25000 Calbiochem CB1001) ( Supplementary Table 1 ). Antibody binding was revealed by using anti-rat or anti-mouse IgG coupled with peroxidase, ECL® (enhanced chemiluminescence) Western Blotting Detection reagents (Amersham Biosciences) and Chemidoc Image system or 3-amino-9-ethylcarbazole as substrate. Images were analysed by Image-J using mean pixel intensity value tool kit.
Immunocytochemistry -Eyes from human as well as mice were embedded in paraffin and 10 μm sections were collected on glass slides. Immunohistochemistry was performed using monoclonal and polyclonal antibodies against several relevant proteins (see list in Supplementary Table 1 ). Primary antibodies were applied after antigen retrieval in citrate buffer (heating for 2 x 3 minutes for mice and 3 x 3 minutes for human samples in microwave at 750 W) followed by blocking for 1 hour in goat serum (1:20, Sigma G9023). Primary and secondary antibodies were applied for 1 hour at room temperature, washed 3 x 5 min with phosphate buffer saline (PBS). TPPP/p25 was visualized using Alexa-Fluor 488 Goat anti-rat secondary antibody (1:1000; Invitrogen A11006). Acetylated tubulin, calbindin and synaptophysin labelling were visualized using Alexa-Fluor 568 Goat anti-mouse secondary antibodies (1:1000; Sigma T7782).
Nuclear staining was performed using Hoechst (0.001 g/ml, Life Technologies H3570).
Samples were imaged using a Zeiss LSM700 confocal microscope through 40x or 63x/1.2 NA Zeiss Neofluar objectives and images generated using the ZEN software package (Zeiss). Central and peripheral retinal images were taken from each section.
Sections from lab water or zinc fed animals were processed in parallel and microscope setting was kept standard between samples for the comparison of immunofluorescence intensities. Images were imported into Image-J and fluorescence intensities were analysed using mean pixel intensity value tool kit.
Immunogold staining -Retina from an unfixed human eye was flat mounted and fixed in 3% formaldehyde and 0.2% glutaraldehyde overnight at 4°C, then washed in PBS.
The macular region was dissected and embedded in 3.6% agarose solution and vibratome sections of 50 μm thickness were cut and collected in a 24 well plate in PBS.
To visualize ultrastructural localization of TPPP/p25 in the retina, sections were processed for pre-embedding immunogold labelling using methods modified from [24, 25] .
The sections were washed in 50 mM glycine solution for 2 hours, then incubated in 10 mM sodium citrate buffer (pH 6.0) for 15 mins using a variable wattage microwave (power at 200 Watts, sample temperature at 45°C; Pelco BioWave, Ted Pella) for antigen retrieval. After rinsing (3x10 mins in PBS), sections were incubated in blocking solution (10% bovine serum albumin (BSA), 5% normal goat serum (NGS), 0.025% Triton-X in PBS) for 1 hour at room temperature. Sections were incubated with the rabbit polyclonal primary antibody against TPPP/p25 (1:100, Novusbio NBP1-80962), first in the microwave (5 mins at 150W, 35°C) and then at 4°C overnight. Sections were rinsed (3x10 mins in 10 mM phosphate buffer with 0.2% Aurion BSA-c) and then incubated in a 6 nm gold-conjugated goat anti-rabbit secondary FAB2 IgG (1:50, Aurion) in the microwave (5 mins at 150W, 35°C), followed by incubation overnight at 4°C. The antibody was diluted in PBS, 0.2% acetylated BSA (BSA-c; Aurion) and 0.025% Triton-X. After antibody incubation steps, sections were rinsed in PBS with 0.2% BSA-c, followed by quick rinses in 20 mM sodium citrate buffer (pH 7.0, 5 mins) then distilled water (1 min). Sections were then processed for silver enhancement of gold-particles, using R-Gent SE-EM kit (Aurion; 60-90 mins), for better visualization of gold label. After rinses in water and PBS, sections were post-fixed in 6% glutaraldehyde and 2% paraformaldehyde solution. Samples were heated in a microwave until sample temperatures reached 30°C (4x5 min 200W). The labelled retina samples were osmicated in 1% osmium solution for 30 minutes at room temperature, incubated in 1.5% aqueous uranyl acetate solution for 90 mins, dehydrated and embedded in Epon-Araldite resin.
Ultra-thin sections of 70-90 nm thickness were cut and collected on pioloform coated copper slot grids. The samples were imaged using at 80kV JOEL JEM-1010 transmission electron microscope.
Statistical analysis -Representative experiments were analysed using Wilcoxon matched-pairs signed rank test to determine differences between two groups. When more than two groups were analysed two results were compared with 2-way ANOVA.
p-values of less than 0.05 were considered significant: *p < 0.05.
RESULTS

TPPP/p25 in the mouse eye
First, we determined the immunolocalization of TPPP/p25 in the ON in mice eyes. The myelin sheath around the ON axons is formed by oligodendroglia and TPPP/p25 has been shown to be present and play a crucial role in the differentiation of oligodendrocytes in the brain [2] . As predicted, there was a strong immunopositivity for TPPP/p25 present in oligodendrocytes in the ON (Fig. 1 ). We found strong TPPP/p25 labelling in the myelinated portion of the ON (Fig. 1A1 ), where the labelling was associated with cell bodies and structures resembling oligodendrocytes and fibres, respectively ( Fig.   1A2 , insert). Immunolabelling was terminated close to the entry of ON into the eye (Fig.   1A1 ) at the area known to be devoid of myelin [26] due to the presence of the lamina cribrosa that prevents the entry of oligodendrocyte precursor cells into the eye to prevent interference with light processing [27, 28] . These observations on mice ON provided support for the specificity of the antibodies we used in our experiments.
TPPP/p25 was localized to the inner plexiform layer (IPL) ( Fig 1A1 and 1B2 ) in sublamina S1, S3 and S5 as distinct puncta (Fig. 1C ). The area occupied by the different TPPP/p25 striations were S1=0-22%, S2=23-29%, S3=30-52%, S4=53-60% and S5=61-100% where S1 was the closest to the inner nuclear layer (INL) and S5 to the ganglion cell layer (GCL) (Supplementary Table 2 ). The full width of the IPL was 100%.
To confirm the definition of S2 and S4, we co-labelled sections with a calbindin specific antibody. Calbindin has been previously shown to localize to S2, S3 and S4 only [29, 30] . Clearly, the labelling of calbindin interposes between the TPPP/p25 labelled sublaminas in S2 and S4 and co-localizes in S3 ( Fig. 1G1-3 ). TPPP/p25 was enriched in a small subset of cell bodies in the INL and GCL in cells immediately adjacent to the IPL ( Fig. 1 B2 , C, F1 and G1). We also found TPPP/p25 immunopositive interplexiform projections to the outer plexiform layer (OPL) through the INL ( Fig. 1 D, arrow) . Due to the punctate appearance of TPPP/p25 immunolabelling in the IPL we speculated that the protein was associated with presynaptic terminals. To determine whether this localization is pre-or postsynaptic we co-labelled sections with TPPP/p25 ( Fig. 1F1 ) and the presynaptic marker synaptophysin (Fig. 1F2 ). The lack of co-localization ( Fig. 1F3) suggested that TPPP/p25 is likely to be associated with postsynaptic boutons. This was most evident in the sublamina S5, where anti-synaptophysin positive nerve endings were surrounded by TPPP/p25 positive structures (see supplementary Fig. S2 ).
TPPP/p25 is involved in tubulin acetylation, therefore, we also assessed whether there is co-localization of TPPP/p25 and acetylated tubulin in the mouse eye. Acetylated tubulin immunoreactivity was present in the ON as well as in the IPL (Fig. 1A1 ) but it appeared that there are areas where there was a lack of co-localization ( Fig 1E1-3 ).
Acetylated tubulin immunoreactivity was associated with discrete filamentous structures in the IPL ( Fig. 1B3 and E2 ; Supplementary figure S1) adjacent to the punctate labelling of TPPP/p25. Acetylated tubulin labelling was the strongest in sublamina S1 and then uniformly distributed in S2-S5 (See supplementary Fig. S1 and Supplementary Table 2 ). Acetylated tubulin immunoreactivity was present throughout the retina (Supplementary figure S1).
To examine further the co-localization of TPPP/p25 and acetylated tubulin, we generated line scans across the areas of interest (Fig 2) . On the ON, there is clear and strong co-localization between the two proteins (Fig 2A) . In the retina, there are areas with full co-localization, but there are areas in which only TPPP/p25 or acetylated tubulin was present ( Fig 2B, arrow heads) .
Effect of zinc supplementation on TPPP/p25 level in mice
After determining TPPP/p25 localization we explored whether experimental manipulation influences TPPP/p25 levels. It has been reported that zinc induced structural rearrangement of TPPP/p25 into the so called molten globule [15] , increased TPPP/p25 levels and tubulin polymerization at cellular level [16, 17] . Zinc is abundantly present in the retina [31] and zinc supplementation has a direct effect on the eye [ 32] . In addition, recent evidence shows ON injury can significantly increase zinc levels, especially in the IPL [19] . Therefore, we examined whether supplementation with zinc could affect TPPP/p25 and/or tubulin acetylation in the mouse eyes. We found that long term zinc supplementation has a lasting effect by significantly increasing TPPP/p25 immunoreactivity ( Fig. 3A) as well as acetylated tubulin immunoreactivity ( Fig 3B) in the IPL.
These effects appear only to be significant in the central but not in the peripheral retina ( Fig. 3) . While the number of sample were low (n=3) to fully assess the sub-laminar changes the immunoreactivity of TPPP/p25 was increased in all striations, while acetylated tubulin immunoreactivity appeared to increase only in S1 (Supplementary Table   2 ).
Localization of TPPP/p25 in the human retina
Localization of TPPP/p25 in the human retina was carried out by labelling fixed and sectioned samples from 5 independent human cadaveric eyes with two different polyclonal antisera. TPPP/p25 immunopositivity was present in the IPL in sublamina S1, S3 and S5 forming distinct puncta (Fig. 4A) . Cytosolic labelling was observed in a subset of neuronal cells immediately adjacent to the IPL in the GCL as well as the INL (Fig. 4B , white arrows) with occasional interplexyform projections to the OPL (Fig 4B, red arrow). Imaging flat-mount retinas we found that <7% of the total numbers of cell (determined by counting labelled nuclei and immunopositive cells) adjacent to the IPL were labelled (Fig. 4C ).
Based on their location immediately adjacent to the IPL we propose that the TPPP/p25 positive cells are amacrine cells. Although the list is growing, over 45 different types of amacrine cells are identified at the inner and outer margin of the INL [30, 33] . Distinguishing amongst the major subtype of amacrine cells is possible by identifying the branching morphology or the neurotransmitter they are enriched in [30, 33] . We examined weather the cells in our experiments are GABA-or glycinergic [30, 34] . Co-labelling the retina with antisera against GABA or glycine and TPPP/p25 showed many GABA/glycine positive cells ( Fig.5A and B , white arrows) but only partial co-localization with TPPP/p25 ( Fig. 5 A and B ; yellow/orange cell bodies). Therefore, no identification based on these neurotransmitters was found. In synaptic terminal in the IPL GABA did not co-localize with TPPP/p25 ( Fig. 5C ) but rather was positioned the opposing side of a synapse, suggesting, just as in mouse, that TPPP/p25 is a postsynaptic protein. To confirm its postsynaptic location human samples were labelled with immunogold for TPPP/p25 which then was silver enhanced for electron microscopy. Immunoelectron microscopy confirmed that TPPP/p25 was indeed in boutons with little or no synaptic vesicles, opposing vesicle-rich boutons ( Fig 5D) .
Finally, we determined the concentration of TPPP/p25 levels in the human retina using retina extracts from three freshly dissected, unfixed cadaveric samples (from donor ages 54, 69 and 74 years old). After flat mounting regions from the central and peripheral retina were excised and homogenized before Western blotting (Fig. 6A) . To quantify protein levels, known amounts of expressed, purified TPPP/p25 was run in parallel with the retinal samples ( Fig. 6A ). We found that TPPP/25 levels were in the range of 0.05-013 ng TPPP/p25 per μg of extracted total protein or 0.6-4.4 µg TPPP/p25 per gram of tissue wet weight. These levels were lower but comparable to TPPP/p25 levels in brain homogenate [3] . We found that TPPP/p25 levels were significantly lower in the peripheral retina compared to the central region ( Fig 6A and B) . Based on the association between TPPP/p25 and tubulin acetylation [5, 35] , we also determined the acetylated tubulin immunoreactivity in human retinal extracts using qualitative Western blot ( Fig. 6D ). We found that while the total tubulin concentrations (determined by quantitative Western blot) were similar in the central and peripheral retina and had little variability between samples (Fig. 6E) , acetylated tubulin levels were highly variable with a trend of lower acetylation levels in the periphery (Fig. 6D ). We found no difference in GAPDH levels which was used as loading control for the experiments (Fig. 6C ).
DISCUSSION
TPPP/p25 is an oligodendrocyte specific neomorphic moonlighting protein with physiological functions involving the enhancement of acetylation and bundling of microtubules and the maintenance of the zinc-rich myelin sheath [2, 3, 5, [15] [16] [17] . In pathology, TPPP/p25 interacts with different proteins like alpha-synuclein [11, [36] [37] [38] forming inclusions [4, 11] . As such TPPP/p25 has multitude of effects that can maintain health or lead to disease. Zinc binds to TPPP/p25 and alters its levels [15, 17] . Therefore, in tissues where changes in zinc levels play a significant role, interaction between TPPP/p25 and zinc can significantly alter its normal and/or pathological function. In the eye, especially in the retina, zinc levels are altered by light dark adaptation [39] or nerve injury [19] and this zinc could alter the levels of proteins like TPPP/p25. In this study, we found that TPPP/p25 has a selective expression in cells resembling amacrine cells and synaptic terminals in the IPL of human as well as mice. We also found that elevated zinc, though oral supplementation, can affect TPPP/p25 level, suggesting that TPPP/p25 may play a role in the organization and reorganization of retinal connection at least partly through promoting tubulin acetylation.
As expected we have detected TPPP/p25 in the oligodendrocytes in the ON as in brain tissue, but not in lamina cribrosa, which stop oligodendrocyte migration in the retina [26] [27] [28] . This observation underlines the specificity of the polyclonal and monoclonal TPPP/p25 antibodies used in this and several previous studies for the identification of TPPP/p25 in oligodendrocytes and as a hallmark protein for synucleinopathies [5, 11, 37, 38] .
There were two major findings in our immunohistochemical studies. We identified TPPP/p25 immunoreactivity in some but not all cell bodies at the inner and outer edges of the IPL, and we found intense punctate labelling in the IPL in striations S1, S3 and S5 both in human and mouse retina ( Fig. 1 and 4) . Previously TPPP/p25 was identified in other retinal layers as well [40, 41] , which could be due to the different sampling/methodologies used in different laboratories. The cells adjacent to the IPL in the INL are amacrine cells [33] , and can be classified in a number of ways into 30-46 different subtypes based on their dendritic arborisation and neurotransmitter content [30] .
Therefore, we propose that the cell bodies positive to TPPP/p25 are amacrine cells: those in the GCL are probably displace amacrine cells [42] while those with projections between the IPL and the OPL are interplexiform amacrine cells [43] (Fig 1 and 4) .
Some of the TPPP/p25 cells contain GABA while others contain glycine as neurotrans-
mitter, but not all GABA or glycine positive cells contain TPPP/p25 (Fig. 5 ). Whether TPPP/p25 positive cells represent a new subclass of amacrine cells is yet to be determined. In the IPL TPPP/p25 appears to be postsynaptically located ( Fig. 1 and 5 ).
Lamina S5 is of special interest because enlarged presynaptic rod bipolar boutons were found to be synaptophysin rich, which are surrounded exclusively by amacrine cell processes [44, 45] and that is what we found in our experiments too (Supplementary Figure S2 ). TPPP/p25 often co-localized with acetylated tubulin (Fig. 2) , which suggests that TPPP/p25 plays a role in organizing and/or reorganizing synaptic connection and as such visual integration through regulating the acetylation of the microtubule network. Our finding on TEM showed that in the IPL TPPP/p25 was in boutons containing few synaptic vesicles and not in the synaptic vesicle rich presynaptic terminals of a bipolar cell. As postsynaptic ganglion cell contains no synaptic vesicles, this finding supports the idea that TPPP/p25 positive boutons belong to amacrine cells [46] . Interestingly, the level of TPPP/p25 in the retina was comparable to that in the brain and higher than in most other tissues [40] .
Finally, the fact that TPPP/p25 and acetylated tubulin levels are significantly altered by zinc supplementation suggest that changes in zinc levels associated to physiological [39] or pathological conditions [19] can influence the organization and reorganization of the synaptic network in the IPL. The most likely mechanism behind the increase in TPPP/p25 levels is the reported zinc involvement in stabilization of the protein [17] .
CONCLUSION
We found that TPPP/p25 is localized to specific areas of the retina and that significant differences do exist between the levels of TPPP/p25 with or without oral zinc supplementation. The co-localization and simultaneous change of TPPP/p25 and acetylated tubulin by zinc supports a microtubule-related function. However, since TPPP/p25 is known to increase the aggregation of proteins like alpha-synuclein [10, 11, 36] , elevated TPPP/p25 levels may also be involved in synaptic dysfunction in the inner retina and may play a role in nerve injury [19] . Therefore, the zinc-mediated TPPP/p25 increase may contribute to normal as well as pathological conditions. Supplementary table 2 . Summary of qualitative fluorescence intensities of different proteins in the IPL in mice eye. TPPP/p25 fluorescence intensity identifies 5 striations in the IPL (S1-S5), with the width of striations noted in the brackets. In these striations the immunolabelling intensity of several proteins was assessed and a summary of fluorescence intensities is listed in the table.
Intensity gradient for each protein is marked by crosses; the number of crosses between columns are not comparable. 
